A股異動 | 激智科技跌近6% 股東擬減持股份
格隆匯8月26日丨激智科技(300566.SZ)現跌5.84%,報17.89元,暫成交9614萬元,最新總市值28億,換手率5.6%。公司上週五公告稱,近日收到持股5%以上的股東、監事俞根偉的《關於股份減持計劃的告知函》。持有公司股份1249.79萬股(佔公司總股本的比例為8.05%)的股東、監事俞根偉擬自本減持計劃公告之日起3個交易日後(8月29日起)至2019年12月31日期間內,以大宗交易方式和集中競價方式減持股份合計不超過216.65萬股,即本次擬減持的股份佔公司總股本的比例不超過1.4%。(行情來源:富途證券)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.